Publication | Closed Access

Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study

Genetic AnalysisEgfr T790mPhase 2BMedicineImmunologyPathologyCancer GenomicsBronchial NeoplasmCancer TreatmentMolecular DiagnosticsCancer GeneticsOncologyRadiation OncologyLung CancerMolecular Oncology